Today’s gaming isn’t tied to a desk it moves with you. That’s why mobile access solutions like idn poker apk are often highlighted in guides, offering players a direct path to competitive tables with optimized performance and intuitive design.

As more players join the digital gaming world, platforms continue to enhance their offerings. Within forums, situs slot idn is commonly referenced when discussing engaging gaming environments. These insights help users explore reliable platforms while enjoying seamless gameplay.

S 44 in Congressional Session 112

Official Summary

 

Bill Number : S 44

 

Title : Medicare Prescription Drug Price Negotiation Act of 2011

 

SUMMARY AS OF:
1/25/2011--Introduced. Medicare Prescription Drug Price Negotiation Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug (MA-PD) plan.

Votes

Title : Medicare Prescription Drug Price Negotiation Act of 2011
Votes in the US Senate
This Bill was not Voted in the US Senate
Votes in the US House
This Bill was not Voted in the US House

Sponsors

 
Congressional Sponsors of S 44
 
Bill Number : S 44

Title : Medicare Prescription Drug Price Negotiation Act of 2011

Sponsor: Sen Klobuchar, Amy [MN] (introduced 1/25/2011)      

ALPHABETICAL [followed by Cosponsors withdrawn]:     (Sort: by date)Sen Begich, Mark [AK] - 1/25/2011
Sen Blumenthal, Richard [CT] - 1/26/2011
Sen Inouye, Daniel K. [HI] - 2/7/2011
Sen Sanders, Bernard [VT] - 1/31/2011

Other Info

Bill Number : S 44

Title : Medicare Prescription Drug Price Negotiation Act of 2011

 
MAJOR ACTIONS:
***NONE***

 
ALL ACTIONS:
 
1/25/2011:Read twice and referred to the Committee on Finance.